AlphaFold predicted structure
DLX5 · P56178

Mean pLDDT
60.7/ 100
Low
289 residues
Confidence breakdown
- Very high(≥ 90)19%
- Confident(70–90)3%
- Low(50–70)40%
- Very low(< 50)38%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
distal-less homeobox 5
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalLimb disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalSkeletal dysplasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalMonogenic hearing loss
Split hand-split foot malformation
split hand-foot malformation 1 with sensorineural hearing loss
Split hand - split foot - deafness
split hand-foot malformation
neurodegenerative disease
male infertility
smoking initiation
attention deficit-hyperactivity disorder
substance abuse
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Homeobox protein DLX-5
Transcriptional factor involved in bone development. Acts as an immediate early BMP-responsive transcriptional activator essential for osteoblast differentiation. Stimulates ALPL promoter activity in a RUNX2-independent manner during osteoblast differentiation. Stimulates SP7 promoter activity during osteoblast differentiation. Promotes cell proliferation by up-regulating MYC promoter activity. Involved as a positive regulator of both chondrogenesis and chondrocyte hypertrophy in the endochondral skeleton. Binds to the homeodomain-response element of the ALPL and SP7 promoter. Binds to the MYC promoter. Requires the 5'-TAATTA-3' consensus sequence for DNA-binding
DLX5 · P56178

Mean pLDDT
60.7/ 100
Low
289 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0